Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 10/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | OGG1 | O15527 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6985317 | 0.87 | NR3C1 (0.58) | NR3C1SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL6977969 | 0.85 | NR3C1 (0.56) | NR3C1SMN1; SMN2MAPTMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6985708 | 0.85 | NR3C1 (0.54) | NR3C1SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL6983499 | 0.84 | NR3C1 (0.59) | NR3C1SMN1; SMN2MAPTKMT2ATP53 | |
| SCHEMBL6982229 | 0.84 | NR3C1 (0.60) | NR3C1SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL6979366 | 0.84 | NR3C1 (0.54) | NR3C1SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL6984817 | 0.84 | NR3C1 (0.54) | NR3C1SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL6987605 | 0.84 | SLC40A1 (0.38) | NR3C1MAPTMEN1KMT2ATP53 | |
| SCHEMBL6984210 | 0.82 | KMT2A (0.55) | NR3C1MEN1KMT2A | |
| SCHEMBL6976398 | 0.81 | NR3C1 (0.51) | NR3C1SMN1; SMN2MEN1KMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0991624-B1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-11-19 | — | — | EP | disclosed |
| US-6300342-B1 | FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION | BOEHRINGER INGELHEIM PHARM KG (DE) | 2001-10-09 | — | — | US | disclosed |